ATLANTA — A federal investigation into Allergan Inc.'s misleading marketing of its wrinkle-smoothing Botox medication is over after a judge in G...
Irena Medavoy | Posted 05.25.2011
Why do all doctors and pharmaceutical companies not disclose conflict of interest information regarding any drug or treatment being prescribed? It seems that all of us as patients have a right to know.
New York Times | NATASHA SINGER | Posted 05.25.2011
Allergan, the maker of Botox, agreed on Wednesday to pay $600 million to settle charges that it illegally promoted and sold the drug through 2005 for ...
Wall Street Journal | RHONDA L. RUNDLE | Posted 05.25.2011
Coming this fall to certain doctors' offices: A new upscale skin-care line from Estée Lauder Cos.' Clinique Laboratories and Botox-maker Allergan Inc...
Los Angeles Times | Lisa Girion | Posted 05.25.2011
In his corner office, Mr. Botox looked his age. He hadn't had a shot of botulinum toxin in a while, and the furrow between his brows was back. "You ...
AP | GREG BLUESTEIN | Posted 11.17.2011